Skip to main content
B

BIO-GENE TECHNOLOGY LTD — Investor Relations & Filings

Ticker · BGT ISIN · AU000000BGT8 ASX Professional, scientific and technical activities
Filings indexed 450 across all filing types
Latest filing 2019-03-26 Regulatory Filings
Country AU Australia
Listing ASX BGT

About BIO-GENE TECHNOLOGY LTD

https://bio-gene.com.au/

Bio-Gene Technology Ltd is a technology company focused on the development and commercialization of novel insecticides derived from naturally occurring chemistry. The company addresses the global challenge of insecticide resistance through its proprietary platform based on beta-triketone chemistry. Its primary product candidates include Flavocide, a nature-identical version of a compound found in specific eucalyptus species, and Qcide, a natural oil extract. These solutions are designed for diverse applications, including crop protection, grain storage, public health, and animal health. By utilizing a unique mode of action, the company provides alternatives to traditional chemical pesticides, aiming to deliver effective pest management with a favorable safety profile for non-target organisms and the environment.

Recent filings

Filing Released Lang Actions
BGT Shareholder Newsletter and Teleconference 1 pag
Regulatory Filings
2019-03-26 English
Change of Director's Interest Notice - D Brumley 2 pages 179.8KB
Regulatory Filings
2019-03-03 English
Change of Director's Interest Notice - R Klupacs 2 pages 180.3KB
Regulatory Filings
2019-02-27 English
Appendix 4D - Half Yearly Report and Accounts - 31/12/18 19 pages 673.1KB
Regulatory Filings
2019-02-19 English
Appendix 4C - 31 December 2018 7 pages 341.8KB
Regulatory Filings
2019-01-30 English
BIO-GENE EXPANDS RESEARCH PROGRAM FOR QCIDE 2 pages 253.2KB
Regulatory Filings
2018-12-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.